Published in Liver Transpl on March 01, 2012
Review of the surgical approach to prevent small-for-size syndrome in recipients after left lobe adult LDLT. Surg Today (2013) 0.98
Small-for-size syndrome in living-donor liver transplantation using a left lobe graft. Surg Today (2014) 0.78
Extracorporeal continuous portal diversion plus temporal plasmapheresis for "small-for-size" syndrome. World J Gastroenterol (2013) 0.78
The outcomes of pediatric living donor liver transplantation using small-for-size grafts: experience of a single institute. Pediatr Surg Int (2016) 0.77
Successful transplantation of small-for-size grafts: a reappraisal. Liver Transpl (2012) 0.75
Risk Factors for Intractable Ascites After Adult-to-Adult Living Donor Liver Transplantation Using Left Lobe. Transplant Direct (2017) 0.75
Should temporary extracorporeal continuous portal diversion replace meso/porta-caval shunts in "small-for-size" syndrome in porcine hepatectomy? World J Gastroenterol (2015) 0.75
Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med (2007) 12.62
Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy. J Hepatol (2003) 6.14
Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma. Gastroenterology (2008) 4.61
Prognostic impact of anatomic resection for hepatocellular carcinoma. Ann Surg (2005) 4.13
Nocturnal oxygen desaturation correlates with the severity of coronary atherosclerosis in coronary artery disease. Chest (2003) 2.36
Regeneration and function of hemiliver graft: right versus left. Surgery (2006) 2.12
High incidence of thrombosis of the portal venous system after laparoscopic splenectomy: a prospective study with contrast-enhanced CT scan. Ann Surg (2005) 2.04
Results of surgical resection for patients with hilar bile duct cancer: application of extended hepatectomy after biliary drainage and hemihepatic portal vein embolization. Ann Surg (2003) 2.04
Poor prognosis associated with thrombocytosis in patients with gastric cancer. Ann Surg Oncol (2002) 2.03
Development of evidence-based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan. Hepatol Res (2008) 1.91
The vessel sealing system (LigaSure) in hepatic resection: a randomized controlled trial. Ann Surg (2009) 1.87
Impact of expression of human epidermal growth factor receptors EGFR and ERBB2 on survival in stage II/III gastric cancer. Clin Cancer Res (2012) 1.74
Role of autonomic tone in the initiation and termination of paroxysmal atrial fibrillation in patients without structural heart disease. J Cardiovasc Electrophysiol (2003) 1.67
Donor complications associated with living donor liver transplantation in Japan. Transplantation (2009) 1.60
Refinement of venous reconstruction using cryopreserved veins in right liver grafts. Liver Transpl (2004) 1.59
Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002). Gastric Cancer (2011) 1.58
Living liver donation: preoperative assessment, anatomic considerations, and long-term outcome. Transplantation (2003) 1.57
S100A expression and interleukin-10 polymorphisms are associated with ulcerative colitis and diarrhea predominant irritable bowel syndrome. Dig Dis Sci (2013) 1.52
Comparison of gene-expression profiles between diffuse- and intestinal-type gastric cancers using a genome-wide cDNA microarray. Oncogene (2004) 1.46
Life-threatening veno-occlusive disease after living-related liver transplantation. Transplantation (2003) 1.46
Antioxidants: benefits and risks for long-term health. Maturitas (2010) 1.46
Ultrasonically assisted retrohepatic dissection for a liver hanging maneuver. Ann Surg (2005) 1.46
AFP, AFP-L3, DCP, and GP73 as markers for monitoring treatment response and recurrence and as surrogate markers of clinicopathological variables of HCC. J Gastroenterol (2010) 1.44
Hepatic arterial anatomy for right liver procurement from living donors. Liver Transpl (2004) 1.44
Evaluation of hepatic venous congestion: proposed indication criteria for hepatic vein reconstruction. Ann Surg (2002) 1.43
Two-stage pancreatojejunostomy in pancreaticoduodenectomy: a retrospective analysis of short-term results. Am J Surg (2008) 1.41
Temporary auxiliary liver transplantation from a living donor to an adult recipient with familial amyloid polyneuropathy. Transplantation (2002) 1.40
Sequential preoperative arterial and portal venous embolizations in patients with hepatocellular carcinoma. Arch Surg (2004) 1.37
Intraoperative fluorescent cholangiography using indocyanine green: a biliary road map for safe surgery. J Am Coll Surg (2008) 1.34
Is there any difference in survival according to the portal tumor thrombectomy method in patients with hepatocellular carcinoma? Surgery (2009) 1.29
Giant spin Hall effect in perpendicularly spin-polarized FePt/Au devices. Nat Mater (2008) 1.28
Expression of twist and wnt in human breast cancer. Anticancer Res (2005) 1.23
Evidence-based Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2013 update (3rd JSH-HCC Guidelines). Hepatol Res (2015) 1.23
Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg (2003) 1.21
A comparison of postoperative quality of life and dysfunction after Billroth I and Roux-en-Y reconstruction following distal gastrectomy for gastric cancer: results from a multi-institutional RCT. Gastric Cancer (2011) 1.19
Significance of alpha-fetoprotein and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma undergoing hepatectomy. Ann Surg Oncol (2009) 1.19
Addition of docetaxel to S-1 without platinum prolongs survival of patients with advanced gastric cancer: a randomized study (START). J Cancer Res Clin Oncol (2013) 1.18
Randomized Controlled Trial to Evaluate Splenectomy in Total Gastrectomy for Proximal Gastric Carcinoma. Ann Surg (2017) 1.16
Efficacy of Rikkunshito, a traditional Japanese medicine (Kampo), in treating functional dyspepsia. Intern Med (2010) 1.15
Oxidative stress caused by inactivation of glutathione peroxidase and adaptive responses. Biol Chem (2003) 1.15
Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma. Arch Surg (2009) 1.15
Upper gastrointestinal ulcer in Japanese patients taking low-dose aspirin. J Gastroenterol (2009) 1.10
MR imaging of the biliary tract with Gd-EOB-DTPA: effect of liver function on signal intensity. Eur J Radiol (2009) 1.10
Surgical treatment of abdominal wall tumor seeding after percutaneous transhepatic biliary drainage. Am J Surg (2007) 1.10
Sling suspension of the liver in donor operation: a gradual tape-repositioning technique. Transplantation (2003) 1.09
Effects of middle hepatic vein reconstruction on right liver graft regeneration. Transplantation (2003) 1.08
Selection for resection of hepatocellular carcinoma and surgical strategy: indications for resection, evaluation of liver function, portal vein embolization, and resection. Ann Surg Oncol (2008) 1.05
Protocol-based noninvasive positive pressure ventilation for acute respiratory failure. J Anesth (2010) 1.05
Vein reconstruction in modified right liver graft for living donor liver transplantation. Ann Surg (2003) 1.04
Enhanced spin accumulation and novel magnetotransport in nanoparticles. Nat Mater (2004) 1.04
Clinical characteristics of Japanese dyspeptic patients: is the Rome III classification applicable? Scand J Gastroenterol (2010) 1.03
Cohort study of the survival benefit of resection for recurrent hepatic and/or pulmonary metastases after primary hepatectomy for colorectal metastases. Ann Surg (2010) 1.02
Duct-to-duct biliary reconstruction in adult living-donor liver transplantation. Transplantation (2004) 1.01
Detection of hepatocellular carcinoma by Gd-EOB-DTPA-enhanced liver MRI: comparison with triple phase 64 detector row helical CT. Eur J Radiol (2010) 1.01
Paraganglioma of the pancreas: a case report and review of the literature. Pancreas (2008) 1.01
Peritoneovenous shunting for intractable chylous ascites complicated with lymphangioleiomyomatosis. Intern Med (2008) 1.01
Value of prophylactic abdominal drainage in 1269 consecutive cases of elective liver resection. J Hepatobiliary Pancreat Sci (2009) 1.01
The role of surgery in the current treatment of gastric carcinoma. Gastric Cancer (2002) 1.00
Tailoring the type of donor hepatectomy for adult living donor liver transplantation. Am J Transplant (2005) 1.00
Right lateral sector graft in adult living-related liver transplantation. Transplantation (2002) 1.00
Induction of protective immunity by vaccination with wild-type apo superoxide dismutase 1 in mutant SOD1 transgenic mice. J Neuropathol Exp Neurol (2010) 1.00
Uracil-tegafur as an adjuvant for hepatocellular carcinoma: a randomized trial. Hepatology (2006) 1.00
The source of moving particles in parafoveal capillaries detected by adaptive optics scanning laser ophthalmoscopy. Invest Ophthalmol Vis Sci (2012) 1.00
Comparison of Billroth I and Roux-en-Y reconstruction after distal gastrectomy for gastric cancer: one-year postoperative effects assessed by a multi-institutional RCT. Ann Surg Oncol (2012) 0.99
Comparison of perioperative and long-term outcomes of total and proximal gastrectomy for early gastric cancer: a multi-institutional retrospective study. World J Surg (2014) 0.98
Value of highly sensitive fucosylated fraction of alpha-fetoprotein for prediction of hepatocellular carcinoma recurrence after curative treatment. Dig Dis Sci (2013) 0.98
Matrix metalloproteinase-7 expression and biologic aggressiveness of cholangiocellular carcinoma. Cancer (2002) 0.98
Results of 404 hepatic resections including 80 repeat hepatectomies for hepatocellular carcinoma. Hepatogastroenterology (2006) 0.97
Pancreaticoduodenectomy after esophageal and gastric surgery preserving right gastroepiploic vessels. Arch Surg (2006) 0.97
Fate of hypointense lesions on Gd-EOB-DTPA-enhanced magnetic resonance imaging. Eur J Radiol (2012) 0.96
Impact of the expression of thymidylate synthase and dihydropyrimidine dehydrogenase genes on survival in stage II/III gastric cancer. Gastric Cancer (2014) 0.96
Induction of thioredoxin reductase as an adaptive response to acrolein in human umbilical vein endothelial cells. Biochem Biophys Res Commun (2005) 0.96
Volume regeneration after right liver donation. Liver Transpl (2004) 0.96
Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg (2004) 0.95
The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol (2008) 0.95
Maternal microchimerism in biliary atresia. J Pediatr Surg (2007) 0.95
Ki-67 and CEA expression as prognostic markers in Dukes' C colorectal cancer. Cancer Lett (2004) 0.95
Progress in surgical treatment of hepatocellular carcinoma. Oncology (2002) 0.93
Overweight is a risk factor for surgical site infection following distal gastrectomy for gastric cancer. Gastric Cancer (2012) 0.93
Safe donor hepatectomy for living related liver transplantation. Liver Transpl (2002) 0.93
Development of hepatic steatosis after pancreatoduodenectomy. AJR Am J Roentgenol (2007) 0.92
Safety of prolonged intermittent pringle maneuver during hepatic resection. Arch Surg (2006) 0.92
Pancreatoduodenectomy with or without early ligation of the inferior pancreatoduodenal artery: comparison of intraoperative blood loss and short-term outcome. World J Surg (2010) 0.91
The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy. J Gastroenterol (2009) 0.91
The role of O-linked GlcNAc modification on the glucose response of ChREBP. Biochem Biophys Res Commun (2010) 0.91
Hepatic resection with reconstruction of the inferior vena cava or hepatic venous confluence for metastatic liver tumor from colorectal cancer. J Am Coll Surg (2004) 0.91
Multi-center phase II study for combination therapy with paclitaxel/doxifluridine to treat advanced/recurrent gastric cancer showing resistance to S-1 (OGSG 0302). Jpn J Clin Oncol (2008) 0.91
Expression of cyclooxygenase-2 in malignant and benign breast tumors. Anticancer Res (2003) 0.90
Identification of genes associated with multiple nodules in hepatocellular carcinoma using cDNA microarray: multicentric occurrence or intrahepatic metastasis? Hepatogastroenterology (2008) 0.90